Oracle JD Edwards EnterpriseOne Tools up to 9.2.8.2 Web Runtime SEC improper authorization
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 4.8 | $0-$5k | 0.00 |
Summary
A vulnerability was found in Oracle JD Edwards EnterpriseOne Tools. It has been declared as critical. This issue affects some unknown processing of the component Web Runtime SEC. Such manipulation leads to improper authorization. This vulnerability is uniquely identified as CVE-2025-21517. The attack can be launched remotely. No exploit exists. It is recommended to upgrade the affected component.
Details
A vulnerability was found in Oracle JD Edwards EnterpriseOne Tools and classified as critical. Affected by this issue is some unknown processing of the component Web Runtime SEC. The manipulation with an unknown input leads to a improper authorization vulnerability. Using CWE to declare the problem leads to CWE-285. The product does not perform or incorrectly performs an authorization check when an actor attempts to access a resource or perform an action. Impacted is integrity, and availability. CVE summarizes:
Vulnerability in the JD Edwards EnterpriseOne Tools product of Oracle JD Edwards (component: Web Runtime SEC). Supported versions that are affected are Prior to 9.2.9.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise JD Edwards EnterpriseOne Tools. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of JD Edwards EnterpriseOne Tools accessible data. CVSS 3.1 Base Score 4.3 (Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:L/A:N).
The advisory is available at oracle.com. This vulnerability is handled as CVE-2025-21517 since 12/25/2024. The exploitation is known to be easy. The attack may be launched remotely. The technical details are unknown and an exploit is not available. The structure of the vulnerability defines a possible price range of USD $0-$5k at the moment (estimation calculated on 03/18/2025). This vulnerability is assigned to T1548.002 by the MITRE ATT&CK project.
Upgrading to version 9.2.9.0 eliminates this vulnerability.
If you want to get best quality of vulnerability data, you may have to visit VulDB.
Product
Type
Vendor
Name
Version
License
Website
- Vendor: https://www.oracle.com
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 4.9VulDB Meta Temp Score: 4.8
VulDB Base Score: 5.4
VulDB Temp Score: 5.2
VulDB Vector: 🔍
VulDB Reliability: 🔍
CNA Base Score: 4.3
CNA Vector (oracle): 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
Exploiting
Class: Improper authorizationCWE: CWE-285 / CWE-266
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: UpgradeStatus: 🔍
0-Day Time: 🔍
Upgrade: JD Edwards EnterpriseOne Tools 9.2.9.0
Timeline
12/25/2024 🔍01/21/2025 🔍
01/21/2025 🔍
03/18/2025 🔍
Sources
Vendor: oracle.comAdvisory: oracle.com
Status: Confirmed
CVE: CVE-2025-21517 (🔍)
GCVE (CVE): GCVE-0-2025-21517
GCVE (VulDB): GCVE-100-292802
Entry
Created: 01/21/2025 22:37Updated: 03/18/2025 04:41
Changes: 01/21/2025 22:37 (65), 03/18/2025 04:41 (1)
Complete: 🔍
Cache ID: 216::103
If you want to get best quality of vulnerability data, you may have to visit VulDB.
No comments yet. Languages: en.
Please log in to comment.